semaglutide for heart failure versus placebo in patients with and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials Medicare Will Cover Wegovy for

Improving metabolic efficiency, reducing the risk of obesity and diabetes

In early human studies, weight reduction persisted beyond the last dose, which fits a drug that lingers and works gradually rather than spiking and crashing

Its important to choose exercises that you enjoy and can sustain long-term, making them a consistent part of your lifestyle rather than a temporary phase

When to contact your GP: Persistent or severe nausea/vomiting preventing adequate fluid intake Severe, persistent abdominal pain which could indicate pancreatitis New or worsening depression, anxiety, or suicidal thoughts Severe headaches or visual disturbances Unexplained cognitive changes or confusion Signs of hypoglycaemia (if taking alongside insulin or sulfonylureas) NICE guidance recommends regular monitoring during GLP-1 receptor agonist therapy